← Leaderboards
Kelly Chibale
University Of Cape Town
$522,344
Attributed
$1,567,031
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $350K · FY2020–24$500K$375K$250K$125K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$1,567,031 · 1
By mechanism
R01$1,567,031 · 1
Top collaborators
- Lori Ferrins5 shared
- Timothy M Willson5 shared
Most similar at University Of Cape Town
Same institution · by research overlap
- Timothy M Willson$15,713,013
- Dan Joseph Stein$9,744,718
- Kathryn Jean Wicht$422,977
- Timothy John Egan$1,350,639
Others in their field
Other Emerging Leaders on “Drug Discovery”
- Leonard Freedman · Leidos Biomedical Research, Inc.$255,277,443
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Lynn Briscoe · Leidos Biomedical Research, Inc.$93,294,869
- John Damon Chodera · Sloan-Kettering Inst Can Research$64,994,606
- Leonard Freedmand · Leidos Biomedical Research, Inc.$52,916,621
- Gary Kobinger · University Of Texas Med Br Galveston$41,631,815
Research focus
Drug DiscoveryDrug KineticsAccountingDrug DevelopmentAffinityArtemisininsAsexualAfricanAffectBloodCancer TherapyCause Of DeathCellsCessation Of LifeChildCollaborationsCombatCombined Modality TherapyBiologicalComputer AssistedCountryDrug CandidateDrug DesignDrug Metabolism
Grant awards (5)
Repurposing kinase inhibitor chemotypes as antimalarials$279,425
R01 · FY2024 · AI · contact PI
Repurposing kinase inhibitor chemotypes as antimalarials$290,699
R01 · FY2023 · AI · contact PI
Repurposing kinase inhibitor chemotypes as antimalarials$304,092
R01 · FY2022 · AI · contact PI
Repurposing kinase inhibitor chemotypes as antimalarials$342,815
R01 · FY2021 · AI · contact PI
Repurposing kinase inhibitor chemotypes as antimalarials$350,000
R01 · FY2020 · AI · contact PI